All patients (n = 587) versus all controls (n = 628)
|
1.58
|
1.09—2.30
|
0.016
|
1.20
|
0.95—1.50
|
0.12
|
1.21
|
1.03—1.44
|
0.024
|
Gender groups
| | | | | | | | | |
Male (124 patients vs. 143controls)
|
0.82
|
0.52—1.28
|
0.33
|
1.13
|
0.44—2.56
|
0.71
|
0.90
|
0.55—1.36
|
0.46
|
Female (453 patients vs. 485 controls)
|
1.89
|
1.25—2.87
|
0.008
|
1.28
|
0.85—1.75
|
0.53
|
1.56
|
1.08—2.49
|
0.012
|
Age groups
| | | | | | | | | |
≤65 years (285 patients vs. 278 controls)
|
1.48
|
1.18—2.36
|
0.028
|
0.95
|
0.68—1.32
|
0.65
|
1.26
|
1.04—1.58
|
0.045
|
>65 years (302 patients vs. 350 controls)
|
1.72
|
1.13—2.53
|
0.020
|
1.13
|
0.84—1.56
|
0.18
|
1.38
|
1.13—1.57
|
0.037
|
K/L grading groups
| | | | | | | | | |
Mild OA (292 patients vs. 628 controls)
|
1.53
|
1.05—2.47
|
0.022
|
1.08
|
0.86—1.29
|
0.31
|
1.30
|
1.05—1.62
|
0.013
|
Severe OA (295 patients vs. 628 controls)
|
1.05
|
0.67—1.64
|
0.84
|
0.95
|
0.70—1.30
|
0.73
|
0.98
|
0.78—1.25
|
0.91
|